Armistice Capital, LLC 13D and 13G filings for Aptose Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:57 pm Sale | 2024-12-31 | 13G | APTOSE BIOSCIENCES INC NO APTO | Armistice Capital, LLC | 34,176 4.990% | -30,997 (-47.56%) | Filing |
| 2024-11-14 3:22 pm Purchase | 2024-09-30 | 13G | APTOSE BIOSCIENCES INC NO APTO | Armistice Capital, LLC | 65,173 9.990% | 65,173 (New Position) | Filing |